Carlyle Group Inc. Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001527166
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q1 2025 · 23 positions · Total reported value $3.80B · Top-10 concentration 99.3% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 21.1% · 0 new · 1 cut · 3 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -16.3% · vs SPY -18.4% · Prev Value $10.00B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -3.8% · vs SPY -6.0% · Latest Value $8.36B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q1 2025 13F filing, Carlyle Group Inc. disclosed 23 equity positions with a combined reported value of $3.80B. The filing implies a focused portfolio: its ten largest positions account for 99.3% of reported value. HoldingsHub classifies the profile as Mid / Focused / Industrials Tilt / High Turnover.
The largest disclosed positions as of Q1 2025 were SARO ($3.58B), SLNO ($61.45M), WRD ($46.45M). By sector, the heaviest allocations are Industrials 94.2%, Technology 1.8%. Versus the prior quarter, allocation shifted toward Industrials (+0.9pp) and away from Health Care (-0.6pp).
Versus the prior quarter, Carlyle Group Inc. opened 0 new positions, trimmed 1 and fully exited 3, a turnover rate of 21.1% of positions. The portfolio's overlap with the prior quarter was 85% of names.
Of the 3 positions fully exited versus the prior quarter, the largest were REPX ($315.34K), HOOD ($232.58K), SYRE ($223.76K).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q1 2025)
No new positions this quarter.
Insider Transactions (Form 4)
Latest Carlyle Group Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
The Carlyle Group was founded in 1987 in Washington, DC by Bill Conway, Dan D'Aniello and David Rubenstein and is one of the largest alternative asset managers in the world. It listed on Nasdaq (CG) in 2012.
Firm Snapshot
It runs three segments: Global Private Equity, Global Credit and Carlyle AlpInvest, its private-funds and secondaries solutions business. The firm describes its model as connecting people, ideas and capital across one network.
Harvey Schwartz has been CEO since 2023.
- Headquarters: WASHINGTON, DC, United States
- SEC registration: 801-52462 (status: Approved), registered 1996-08-06
- Regulatory AUM (Form ADV): $200.75B as of 2026-07-07
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 314 private funds, of which 1 hedge funds
Portfolio Structure
- 16 positions · $8.36B reported value (Q3 2026)
- Top 10 holdings = 100.0% of reported value
- Largest position: MDLN (MEDLINE INC) at 77.6%
- Average position size: $522.59M
Sector Tilt
- Health Care 78.0%
- Industrials 21.6%
- Information Technology 0.2%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q3 2026: 2 added, 1 reduced, 3 exited
- 13 positions unchanged
Reading the 13F
The 13F is a rounding error at Carlyle: most assets are unlisted company equity, private credit and fund interests that 13F never captures. What appears here — listed vehicles and CLO-related holdings — is a side sleeve.
The firm background and strategy notes are written by HoldingsHub editors from public sources; holdings, trading and Form ADV figures come from the firm's public SEC filings. Not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
134.35M | $3.58B | 94.10% | Add | |
| 2 |
|
860.98K | $61.45M | 1.61% | Reduce | |
| 3 |
|
3.42M | $46.45M | 1.22% | Hold | |
| 4 |
|
3.50M | $21.92M | 0.58% | Hold | |
| 5 |
|
2.36M | $20.84M | 0.55% | Hold | |
| 6 |
|
477.50K | $16.64M | 0.44% | Hold | |
| 7 |
|
6.23M | $10.79M | 0.28% | Reduce | |
| 8 |
|
220.50K | $9.42M | 0.25% | Hold | |
| 9 |
|
1.36M | $6.86M | 0.18% | Hold | |
| 10 |
|
4.36M | $4.89M | 0.13% | Reduce | |
| 11 |
|
1.07M | $4.58M | 0.12% | Hold | |
| 12 |
|
281.64K | $3.58M | 0.09% | Hold | |
| 13 |
|
1.98M | $3.08M | 0.08% | Hold | |
| 14 |
|
107.21K | $2.67M | 0.07% | Hold | |
| 15 |
|
1.84M | $2.65M | 0.07% | Hold | |
| 16 |
|
2.95M | $2.28M | 0.06% | Hold | |
| 17 |
|
1.10M | $1.81M | 0.05% | Hold | |
| 18 |
|
340.75K | $1.68M | 0.04% | Hold | |
| 19 |
|
269.89K | $1.16M | 0.03% | Hold | |
| 20 |
|
2.90M | $840.28K | 0.02% | Hold | |
| 21 |
|
93.73K | $664.56K | 0.02% | Hold | |
| 22 |
|
5.48K | $218.56K | 0.01% | Reduce | |
| 23 |
|
133.33K | $116.00K | 0.00% | Hold | |
FAQ
What did Carlyle Group Inc. buy in 2025-Q1?
In its 2025-Q1 13F filing, Carlyle Group Inc. reported 23 equity positions worth $3.80B in aggregate; its largest disclosed positions were SARO ($3.58B), SLNO ($61.45M), WRD ($46.45M).
How large is Carlyle Group Inc.'s portfolio?
Carlyle Group Inc. reported $3.80B of long equity holdings across 23 positions as of 2025-Q1. Top-10 holdings account for 99.3% of reported value.
What is Carlyle Group Inc.'s investment style?
HoldingsHub classifies the portfolio as Mid / Focused / Industrials Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.